Lin BioScience, Inc. (TPEX:6696)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
164.50
-4.00 (-2.37%)
Aug 12, 2025, 1:57 PM CST
-2.37%
Market Cap13.94B
Revenue (ttm)n/a
Net Income (ttm)-744.27M
Shares Out82.73M
EPS (ttm)-9.47
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,000
Average Volume693,446
Open167.00
Previous Close168.50
Day's Range163.00 - 170.00
52-Week Range88.40 - 180.50
Beta-0.03
RSI75.78
Earnings DateAug 13, 2025

About Beacon Roofing Supply

Lin BioScience, Inc., a drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases. Its product pipeline includes LBS-008, an oral therapy for dry age-related macular degeneration (Dry AMD)and stargardt diseases (STGD1), which is under Phase 3 clinical trial to evaluate safety and efficacy in adolescent STGD1 and under phase 2 or phase 3 clinical trial to evaluate safety and efficacy in Dry AMD; LBS-007, a natural non-ATP CDC7 inhibitor for the treatment of cancers; LBS-002, an anti-tubulin to treat primary... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Zhengqi Wang
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6696
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.